Archives
-
TMEM16F Lipid Scrambling in Ferroptosis and Immunity
2026-08-25
Yang et al. identify TMEM16F-mediated phospholipid scrambling as a late-stage suppressor of ferroptosis that protects plasma-membrane integrity after lipid peroxide accumulation. Loss of this membrane-remodeling response promotes lytic death, danger-signal release, slower tumor growth, and stronger responses to PD-1 blockade, providing a mechanistic link between ferroptosis execution and tumor immune rejection.
-
PTSD Mice Reveal a Vagal Heart–Insula Circuit
2026-08-25
A 2026 European Journal of Pharmacology study identifies a vagus-dependent cardiac-to-insular pathway linking sympathetic cardiac overactivation with PTSD-like behavior in mice. Its combination of isoproterenol challenge, vagotomy, electrophysiology, and propranolol treatment provides a mechanistic framework for studying heart–brain signaling while highlighting the limits of translating a mouse model into human PTSD.
-
Cyanidin Chloride: Designing Better Redox Assays
2026-08-24
Cyanidin Chloride is an anthocyanin polyphenolic antioxidant for rigorous oxidative stress research. This guide focuses on identity-aware assay design, linking chemical redox measurements with inflammatory and epithelial cell readouts while distinguishing direct aglycone evidence from related glycoside findings.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-08-24
HyperFluor 488 Goat Anti-Rabbit IgG is a fluorescent antibody conjugate for detecting rabbit IgG primary antibodies in fluorescence-based assays. It is suited to immunofluorescence, immunocytochemistry, immunohistochemistry fluorescent detection, flow cytometry, and fluorescence microscopy, but should not be treated as a universal secondary or used in sodium azide-incompatible workflows without validation.
-
DiscoveryProbe Stem Cell Compound Library Plus
2026-08-23
DiscoveryProbe Stem Cell Compound Library Plus enables mechanism-guided stem cell pathway profiling and phenotypic screening. This article explains how evidence from a high-content parasite stem-cell screen can improve hit triage, orthogonal validation, and assay design without overextending the biology.
-
p-Cresyl Metabolites in Biliary Epithelial Injury
2026-08-22
The reference study shows that the gut microbial metabolites p-cresyl sulfate and p-cresyl glucuronide can promote biliary epithelial cell apoptosis and hepatic inflammation in complementary in vitro and mouse experiments. Its main contribution is to connect Clostridium-derived phenolic metabolism with potential hepatobiliary immune injury, while also defining experimental readouts that can be adapted for mechanistic studies.
-
Uremic Metabolite Adsorption on Hydroxy-PEO Films
2026-08-22
This 2025 study examines how hydroxy-terminated polyethylene oxide films interact with a complex mixture of 25 uremic metabolites, rather than evaluating isolated toxins under simplified conditions. Its results show that adsorption depends on metabolite structure, PEO chain density, incubation time, and terminal chemistry, providing an important framework for designing low-fouling blood-contacting biomaterials under disease-relevant conditions.
-
Tropifexor (LJN452) for FXR Barrier Studies
2026-08-21
Learn how to apply Tropifexor as a high-affinity FXR signaling pathway modulator in intestinal barrier, organoid, metabolic, and liver disease model workflows. This guide translates piglet and patient-derived organoid findings into practical dosing, readout, and troubleshooting strategies.
-
LY2109761: Translating TGF-β Signaling
2026-08-20
A translational framework for using LY2109761, a TGF-β receptor type I and II dual inhibitor, to connect receptor biochemistry with Smad2/3 signaling, tumor biology, radiosensitization, and fibrosis research.
-
EdU Imaging Kits: Linking S-Phase to HCC Risk
2026-08-20
EdU Imaging Kits (HF488) connect direct S-phase DNA synthesis measurement with modern hepatocellular carcinoma research. This guide explains how click chemistry can validate AI-derived risk signatures, distinguish proliferation phenotypes, and strengthen microscopy or flow cytometry workflows.
-
Cyanin Chloride in a HaCaT Psoriasis Model
2026-08-19
The 2024 reference study integrates chemical antioxidant assays, macrophage inflammation testing, cytokine-stimulated HaCaT keratinocytes, STAT3 analysis, and epithelial barrier measurements to examine cyanin chloride in a psoriasis-relevant in vitro system. Its main contribution is linking suppression of inflammatory signaling with recovery of barrier function, while the compound identity and in vitro design define important limits for translation.
-
Palmitic acid (N2456): Protocol & QC Guide
2026-08-19
Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a defined saturated long-chain fatty acid for solvent-controlled studies of lipid metabolism, inflammation, and cellular signaling. It is appropriate for non-aqueous preparation workflows but should not be selected for aqueous-only assays or protocols requiring long-term storage of prepared solutions.
-
Tigecycline Workflows for Resistance Research
2026-08-18
Build more informative multidrug-resistance assays with Tigecycline, a glycylcycline antibiotic that links genotype, susceptibility, and infection-model readouts. This guide emphasizes practical stock preparation, MIC design, MRSA and CREC applications, and troubleshooting for reproducible results.
-
p-Cresyl Sulfate and Aortic Valve Calcification
2026-08-18
The reference study shows that p-cresyl sulfate promotes calcification of porcine aortic valvular interstitial cells through a signaling pattern involving HIF-1α activation, klotho loss, and NF-κB/RUNX2 regulation. Klotho supplementation and pharmacological SIRT1 activation reduced these responses in cell and rat CKD models, identifying a mechanistic link between uremic toxin accumulation and calcific aortic valve disease.
-
FGF4–FGFR1 Signaling Protects Podocytes in DKD
2026-08-17
This Nature Communications study identifies podocyte-secreted FGF4 as an endogenous protective factor in diabetic kidney disease and links its loss to podocyte depletion and declining glomerular function. Genetic deletion, recombinant FGF4 rescue, and human podocyte experiments support an FGFR1–AMPK–FOXO1 mechanism that limits oxidative stress and apoptosis, providing a mechanistic basis for future podocyte-directed therapies.